Q3 2022 Eris Lifesciences Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to the Q3 and 9M FY '22 Conference Call of Eris Lifesciences.
We have with us on the call today, Mr. Amit Bakshi, Chairman and Managing Director; and Mr. V. Krishnakumar, Chief Operating Officer and Executive Director. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. V Krishnakumar, Chief Operating Officer and Executive Director of the company. Thank you, and over to you, sir.
Thank you. Good afternoon, and welcome to our third quarter conference call. I'm Krishnakumar, and I'm happy to share the highlights of the quarter with you.
As per the AIOCD retail audit, the Indian pharma market grew at 5.7% in quarter 3 of this year on the back of a 6.4% growth in quarter 3 of last year. In comparison, I'm happy to share that Eris grew at 7.8% in quarter 3 of this year on the back of a 14.5% growth in quarter 3 of last year. If you look at the first 9
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
